Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | FHOD3 |
| Upstream (Parents) |
|---|
| (<<) KIRREL → FHOD3 |
| (<<) GPR161 → FHOD3 |
| (<<) SH3PXD2A → FHOD3 |
| (<<) B4GALT6 → FHOD3 |
| (<<) COL8A2 → FHOD3 |
| (<<) GJA1 → FHOD3 |
| Downstream (Children) |
|---|
| FHOD3 → GPX7 (>>) |
| FHOD3 → PRR16 (>>) |
| FHOD3 → CDC42EP3 (>>) |
| FHOD3 → ZNF503 (>>) |
| FHOD3 → SMAD7 (>>) |
| FHOD3 → SCUBE3 (>>) |
| FHOD3 → PAPPA (>>) |
| FHOD3 → GPR161 (>>) |
| FHOD3 → LEPREL1 (>>) |
| FHOD3 → SLC24A3 (>>) |
| FHOD3 → HECW2 (>>) |
| FHOD3 → B4GALT6 (>>) |
| FHOD3 → DSC1 (>>) |
| FHOD3 → SATB2 (>>) |
| FHOD3 → LRRC49 (>>) |
| FHOD3 → NALCN (>>) |
| FHOD3 → NINJ2 (>>) |
